Home
Browse
Search
Statistics
About
Usage
PMID: 9511932
Clancy JP, Bebok Z, Sorscher EJ
Purification, characterization, and expression of CFTR nucleotide-binding domains.
J Bioenerg Biomembr. 1997 Oct;29(5):475-82.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
60
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9511932:60:157
status:
NEW
view ABCC7 p.Gly551Asp details
(6,17) NUCLEOTIDE BINDING BY CFTR NBD-1 In Vitro The second most common CFTR mutation is the replacement of a glycine by aspartic acid at CFTR position 551 (
G551D
).
Login to comment
62
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9511932:62:114
status:
NEW
view ABCC7 p.Gly551Asp details
We studied the nucleotide binding characteristics of the wild type CFTR NBD-1, and also NBD-1 containing AF508 or
G551D
.
Login to comment
63
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9511932:63:119
status:
NEW
view ABCC7 p.Gly551Asp details
As shown in Fig. 2, while the AF508 mutation had no effect on binding of the nucleotide analog trinitrophenol ATP, the
G551D
mutation significantly decreased nucleotide binding by this recombinant CFTR domain.
Login to comment
64
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 9511932:64:160
status:
NEW
view ABCC7 p.Gly1349Asp details
To confirm that glycine within this motif was important in nucleotide interactions, the corresponding glycine-aspartic acid replacement was made in CFTR NBD-2 (
G1349D
), and nucleotide binding was compared with thepurified wild type region.
Login to comment
65
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 9511932:65:40
status:
NEW
view ABCC7 p.Gly1349Asp details
The clinically important NBD-2 mutation
G1349D
led to decreased nucleotide binding by NBD-2.
Login to comment
72
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9511932:72:57
status:
NEW
view ABCC7 p.Gly551Asp details
CFTR NBD-1, as well as NBD-1containing the AF508 and the
G551D
mutations,were dissolvedin 10 mM Tris, pH 7.4.
Login to comment
75
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 9511932:75:40
status:
NEW
view ABCC7 p.Gly1349Asp details
NBD-2 polypeptides with and without the
G1349D
mutation were compared by trinitrophenol ATP binding.
Login to comment
76
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 9511932:76:4
status:
NEW
view ABCC7 p.Gly1349Asp details
The
glycine-to-aspartic acid mutation at position 1349
substantially decreased the affinity of the second nucleotide binding domain for TNP-ATP.
Login to comment
79
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9511932:79:97
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9511932:79:173
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9511932:79:246
status:
NEW
view ABCC7 p.Gly551Asp details
(18) An alternative explanation, that in vitro folding of the domain is grossly disrupted by the
G551D
mutation, was also considered, However, the CD spectrum of the folded
G551D
NBD-1 did not differ from either AF508 or wild type NBD-1, and the
G551D
CFTR protein is not recognized as misfolded, at least insofar as the cellular quality control pathways responsible for CFTR processing are concerned.
Login to comment
80
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9511932:80:118
status:
NEW
view ABCC7 p.Gly551Asp details
Nevertheless, high-resolution structural studies will be necessary in order to determine whether decreased binding by
G551D
NBD-1 is due to a replacement of a neutral residuewith an exposed negatively charged aspartic acid, possibly blocking entry of negatively charged ATP molecules into a nucleotide binding pocket within the NBD-1.
Login to comment
116
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9511932:116:46
status:
NEW
view ABCC7 p.Gly551Asp details
This finding supports other observations that
G551D
is normally processed to the plasma membrane, but maintains little or no residual function.
Login to comment